373 related articles for article (PubMed ID: 19503104)
1. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for engagement by complement factor H of C3b on a self surface.
Morgan HP; Schmidt CQ; Guariento M; Blaum BS; Gillespie D; Herbert AP; Kavanagh D; Mertens HD; Svergun DI; Johansson CM; Uhrín D; Barlow PN; Hannan JP
Nat Struct Mol Biol; 2011 Apr; 18(4):463-70. PubMed ID: 21317894
[TBL] [Abstract][Full Text] [Related]
3. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses.
Xue X; Wu J; Ricklin D; Forneris F; Di Crescenzio P; Schmidt CQ; Granneman J; Sharp TH; Lambris JD; Gros P
Nat Struct Mol Biol; 2017 Aug; 24(8):643-651. PubMed ID: 28671664
[TBL] [Abstract][Full Text] [Related]
4. Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
Osborne AJ; Nan R; Miller A; Bhatt JS; Gor J; Perkins SJ
J Biol Chem; 2018 Nov; 293(44):17166-17187. PubMed ID: 30217822
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
6. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
[TBL] [Abstract][Full Text] [Related]
7. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
8. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
9. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of the product of disease-related factor H gene conversion.
Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
[TBL] [Abstract][Full Text] [Related]
11. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
[TBL] [Abstract][Full Text] [Related]
12. Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus).
Pechtl IC; Neely RK; Dryden DT; Jones AC; Barlow PN
Protein Sci; 2011 Dec; 20(12):2102-12. PubMed ID: 21936007
[TBL] [Abstract][Full Text] [Related]
13. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.
Pechtl IC; Kavanagh D; McIntosh N; Harris CL; Barlow PN
J Biol Chem; 2011 Apr; 286(13):11082-90. PubMed ID: 21270465
[TBL] [Abstract][Full Text] [Related]
16. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
Front Immunol; 2021; 12():615748. PubMed ID: 33732239
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH).
Morgan HP; Mertens HD; Guariento M; Schmidt CQ; Soares DC; Svergun DI; Herbert AP; Barlow PN; Hannan JP
PLoS One; 2012; 7(2):e32187. PubMed ID: 22389686
[TBL] [Abstract][Full Text] [Related]
19. Complement Evasion Mediated by Enhancement of Captured Factor H: Implications for Protection of Self-Surfaces from Complement.
Herbert AP; Makou E; Chen ZA; Kerr H; Richards A; Rappsilber J; Barlow PN
J Immunol; 2015 Nov; 195(10):4986-98. PubMed ID: 26459349
[TBL] [Abstract][Full Text] [Related]
20. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
Jokiranta TS; Jaakola VP; Lehtinen MJ; Pärepalo M; Meri S; Goldman A
EMBO J; 2006 Apr; 25(8):1784-94. PubMed ID: 16601698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
